An ad hoc planning committee will plan and conduct a public workshop to examine and discuss transparency in medical research. The goal of the workshop will be to examine the effect of current conflict of interest regulations on medical innovation. The workshop will advance discussions among a broad array of stakeholders, which may include government officials, pharmaceutical company representatives, academic researchers, regulators, funders, providers, and patients. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually authored summary of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures.